Literature DB >> 15139465

The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era.

B J Marais1, R P Gie, H S Schaaf, A C Hesseling, C C Obihara, L J Nelson, D A Enarson, P R Donald, N Beyers.   

Abstract

The pre-chemotherapy literature represents an impressive body of evidence that clarifies important epidemiological concepts in childhood tuberculosis. Reports describe the major transitions in tuberculosis, from exposure to infection and from infection to disease (morbidity and mortality), without the influence of chemotherapy. Children with household exposure to a sputum smear-positive source case experienced the greatest risk of becoming infected and of developing subsequent disease. Household exposure to a sputum smear-negative source case or non-household exposure still posed an appreciable, although greatly reduced, risk. Infection in children less than 2 years of age indicated a probable household source case. The majority of older children who were infected did not have a household source identified, and presumably became infected in the community. The annual risk of infection (ARI) was not constant across all ages, but seemed to increase during periods of widening social contact. Infants and adolescents were the groups at highest risk for disease development and death following primary infection.

Entities:  

Mesh:

Year:  2004        PMID: 15139465

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  76 in total

1.  CD8+ T cells provide an immunologic signature of tuberculosis in young children.

Authors:  Christina Lancioni; Melissa Nyendak; Sarah Kiguli; Sarah Zalwango; Tomi Mori; Harriet Mayanja-Kizza; Stephen Balyejusa; Megan Null; Joy Baseke; Deo Mulindwa; Laura Byrd; Gwendolyn Swarbrick; Christine Scott; Denise F Johnson; LaShaunda Malone; Philipa Mudido-Musoke; W Henry Boom; David M Lewinsohn; Deborah A Lewinsohn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

2.  Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.

Authors:  E R Maritz; G Montepiedra; L Liu; C D Mitchell; S A Madhi; R Bobat; A Violari; A Ogwu; A C Hesseling; M F Cotton
Journal:  Int J Tuberc Lung Dis       Date:  2016-08       Impact factor: 2.373

3.  A relook at preventive therapy for tuberculosis in children.

Authors:  Varinder Singh; Soumya Patra
Journal:  Indian J Pediatr       Date:  2010-10-27       Impact factor: 1.967

4.  Two methods for setting child-focused tuberculosis care targets.

Authors:  C M Yuen; H E Jenkins; R Chang; J Mpunga; M C Becerra
Journal:  Public Health Action       Date:  2016-06-21

5.  Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.

Authors:  D Jerene; W Abebe; K Taye; P G Suarez; Y Feleke; I Hallström; A J Ruff
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

Review 6.  A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children.

Authors:  Kyle John Wilby; Sara Shabana; Mary H H Ensom; Fawziah Marra
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

Review 7.  Tuberculosis in Children.

Authors:  Tania A Thomas
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

Review 8.  Tuberculosis susceptibility and protection in children.

Authors:  Robindra Basu Roy; Elizabeth Whittaker; James A Seddon; Beate Kampmann
Journal:  Lancet Infect Dis       Date:  2018-10-12       Impact factor: 25.071

Review 9.  Infectious Diseases of Poverty in Children: A Tale of Two Worlds.

Authors:  Caitlin Hansen; Elijah Paintsil
Journal:  Pediatr Clin North Am       Date:  2016-02       Impact factor: 3.278

10.  The transmission dynamics of tuberculosis in a recently developed Chinese city.

Authors:  Peng Wu; Eric H Y Lau; Benjamin J Cowling; Chi-Chiu Leung; Cheuk-Ming Tam; Gabriel M Leung
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.